Cargando…

Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge

We report a patient with advanced bladder cancer in which the primary lesion and metastatic site disappeared following the pembrolizumab therapy rechallenge after radiotherapy for bladder cancer lesion of nonresponse of pembrolizumab first challenge. A 76-year-old man with advanced bladder cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Taro, Hasegawa, Go, Kawaguchi, Gen, Ikeda, Yohei, Hara, Noboru, Nishiyama, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337140/ https://www.ncbi.nlm.nih.gov/pubmed/34367712 http://dx.doi.org/10.1155/2021/9087529

Ejemplares similares

Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report
por: Hasegawa, Moto, et al.
Publicado: (2020)

Complete remission following pembrolizumab therapy for a patient with nephroureterectomy positive-margin carcinoma in situ and bladder cancer unresponsive to Bacille Calmette–Guérin therapy
por: Nakamura, Ryohta, et al.
Publicado: (2023)

Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
por: Nakamura, Ryohta, et al.
Publicado: (2022)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)

Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer
por: Kawaguchi, Gen, et al.
Publicado: (2023)

Laparoscopic Nephroureterectomy with Heminephrectomy for Urothelial Carcinoma of the Upper Renal Pelvis on the Left Side of the Horseshoe Kidney
por: Ikeda, Taro, et al.
Publicado: (2022)

Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
por: Eldani, Céline, et al.
Publicado: (2023)

Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
por: Murata, Masaki, et al.
Publicado: (2019)

Urothelial carcinoma with sarcomatoid/osteosarcoma variant of the bladder: A case report
por: Murata, Masaki, et al.
Publicado: (2020)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab
por: Hatayama, Tomoya, et al.
Publicado: (2020)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

A case of cabozantinib therapy leading to complete remission for massive intra-intestinal bleeding and worsening metastatic sites following nivolumab and ipilimumab therapy
por: Ishida, Kyohei, et al.
Publicado: (2023)

Urothelial carcinoma with sarcomatous variant of the bladder following radiotherapy for cervical cancer: A case report
por: Inui, Kohei, et al.
Publicado: (2018)

Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab
por: Arai, Takayuki, et al.
Publicado: (2021)

Simultaneous Laparoscopic Surgery for Bladder Diverticulum and Urachal Remnant: A Case Report
por: Murata, Masaki, et al.
Publicado: (2019)

Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab
por: Nezu, Kunihisa, et al.
Publicado: (2021)

Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report
por: Trabjerg, Natacha Dencker, et al.
Publicado: (2019)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab
por: Minchom, Anna, et al.
Publicado: (2020)

Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
por: Ikeda, Yuki, et al.
Publicado: (2021)

Primary lung sebaceous carcinoma successfully treated with radiotherapy and pembrolizumab: A case report
por: Jodai, Yasumiko, et al.
Publicado: (2022)

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature
por: Carausu, Marcela, et al.
Publicado: (2019)

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer
por: Isono, Taisuke, et al.
Publicado: (2021)

Pembrolizumab for all
por: Kim, Myung S., et al.
Publicado: (2022)

Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
por: Kalmuk, James, et al.
Publicado: (2020)

Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review
por: Hinata, Yudai, et al.
Publicado: (2021)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy
por: Marcrom, Samuel, et al.
Publicado: (2017)

Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides
por: Walker, Christina J., et al.
Publicado: (2020)

Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2022)

Testicular Seminoma With Pseudocyst and Coagulation Necrosis Like Burned-out Tumor: A Case Report
por: Hoshii, Tatsuhiko, et al.
Publicado: (2016)

Into the Clinic With Nivolumab and Pembrolizumab
por: Shu, Catherine A., et al.
Publicado: (2016)

Pembrolizumab-associated sarcoidosis
por: Cotliar, Jonathan, et al.
Publicado: (2016)

Pembrolizumab-induced pneumonitis
por: Leroy, Vincent, et al.
Publicado: (2017)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Granulocytic/myeloid sarcoma with trisomy 21 presented as an epididymal tumor: A case report and review of the literature
por: Murata, Masaki, et al.
Publicado: (2020)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Challenging the standard of care in advanced melanoma: focus on pembrolizumab
por: Abdul-Karim, Raghad M, et al.
Publicado: (2017)

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
por: Fujimoto, Daichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s1a2c57vhbsjce39o5f2j5k7r1